Furthermore, ST2 is upregulated on the surface of CD34+ hematopoietic stem/progenitor cells (HSPCs) of BCR-ABL1-positive and -negative MPN patients, compared to healthy donors (101, 102). Here, CD34 is linked to myeloproliferative neoplasm.